Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors

[1]  Guo-Qing Song,et al.  Kisspeptin 10 inhibits the Warburg effect in breast cancer through the Smad signaling pathway: both in vitro and in vivo. , 2016, American journal of translational research.

[2]  Yi Zhang,et al.  Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice , 2016, Parasites & Vectors.

[3]  Sunita Gakkhar,et al.  Comparative Genome and Network Centrality Analysis to Identify Drug Targets of Mycobacterium tuberculosis H37Rv , 2015, BioMed research international.

[4]  Jie Zhang,et al.  Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma , 2015, International journal of molecular sciences.

[5]  Staffan Eriksson,et al.  Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung. , 2014, International journal of clinical and experimental medicine.

[6]  Hajime Saito,et al.  Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer , 2014, Tumor Biology.

[7]  Hua Long,et al.  Proteomic profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as negative survival markers of human osteosarcoma , 2014, Molecular carcinogenesis.

[8]  Yang Song,et al.  Fructose-Bisphosphate Aldolase A Is a Potential Metastasis-Associated Marker of Lung Squamous Cell Carcinoma and Promotes Lung Cell Tumorigenesis and Migration , 2014, PloS one.

[9]  Z. Ding,et al.  Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis. , 2014, International journal of clinical and experimental pathology.

[10]  Andrzej Gamian,et al.  Nuclear localization of aldolase A correlates with cell proliferation. , 2013, Biochimica et biophysica acta.

[11]  Elizabeth Stephan,et al.  PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. , 2013, Surgery.

[12]  P. Jiang,et al.  Maternal Embryonic Leucine Zipper Kinase (MELK): A Novel Regulator in Cell Cycle Control, Embryonic Development, and Cancer , 2013, International journal of molecular sciences.

[13]  Yonghong Sun,et al.  PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. , 2013, Carcinogenesis.

[14]  Long Bai,et al.  CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer , 2013, Journal of Translational Medicine.

[15]  Gang Chen,et al.  Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix , 2013, BMC Cancer.

[16]  D. Lowy,et al.  The Expression of Glyceraldehyde-3-Phosphate Dehydrogenase Associated Cell Cycle (GACC) Genes Correlates with Cancer Stage and Poor Survival in Patients with Solid Tumors , 2013, PloS one.

[17]  Zhifu Sun,et al.  Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients. , 2013, Lung cancer.

[18]  R. Albulescu.  Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome. , 2013, Biomarkers in medicine.

[19]  Taner Korkmaz,et al.  Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[20]  G. Semenza,et al.  Emerging roles of PKM2 in cell metabolism and cancer progression , 2012, Trends in Endocrinology & Metabolism.

[21]  Carolyn Ritterson Lew,et al.  Targeting of Several Glycolytic Enzymes Using RNA Interference Reveals Aldolase Affects Cancer Cell Proliferation through a Non-glycolytic Mechanism , 2012, The Journal of Biological Chemistry.

[22]  Mats Lambe,et al.  Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation , 2012, Clinical Cancer Research.

[23]  Xiayu Li,et al.  New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. , 2012, Molecular bioSystems.

[24]  A. Carvalho,et al.  Identification of upregulated genes in oral squamous cell carcinomas , 2012, Head & neck.

[25]  Tatsuya Kato,et al.  Overexpression of CDC20 predicts poor prognosis in primary non‐small cell lung cancer patients , 2012, Journal of surgical oncology.

[26]  Haiyuan Yu,et al.  Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[27]  Peter M Schlag,et al.  Identification of early molecular markers for breast cancer , 2011, Molecular Cancer.

[28]  Stephanie Roessler,et al.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.

[29]  Chi-Ying F. Huang,et al.  Malignant pleural effusion cells show aberrant glucose metabolism gene expression , 2010, European Respiratory Journal.

[30]  J. Fregnani,et al.  Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. , 2010, Human pathology.

[31]  Hiroshi Hosoya,et al.  Fructose-1,6-bisphosphate aldolase A is involved in HaCaT cell migration by inducing lamellipodia formation. , 2010, Journal of dermatological science.

[32]  W. V. van IJcken,et al.  Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.

[33]  R. Sutherland,et al.  Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer , 2009, Histopathology.

[34]  M. Roehrl,et al.  Glycoproteomic Analysis of Human Lung Adenocarcinomas Using Glycoarrays and Tandem Mass Spectrometry: Differential Expression and Glycosylation Patterns of Vimentin and Fetuin A Isoforms , 2009, The protein journal.

[35]  H. Nevanlinna,et al.  High cyclin B1 expression is associated with poor survival in breast cancer , 2009, British Journal of Cancer.

[36]  M. Mansukhani,et al.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression , 2008, Genes, chromosomes & cancer.

[37]  C. You,et al.  [Impact of all-trans retinoic acid on gene expression profile of glioblastoma cell line SHG-44]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[38]  F. Grosse,et al.  Human Cdc45 is a proliferation‐associated antigen , 2007, The FEBS journal.

[39]  Alon Geva,et al.  Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr). , 2004, Blood.

[40]  Atul J. Butte,et al.  Quantifying the relationship between co-expression, co-regulation and gene function , 2004, BMC Bioinformatics.

[41]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[42]  Y. Lee,et al.  Glucose deprivation-induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and bcl-2 in apoptotic cell death. , 1997, Journal of cell science.

[43]  J. Moore,et al.  BioData Mining , 2017 .

[44]  Yoshio Kiyohara,et al.  Identification of melanoma antigens using a Serological Proteome Approach (SERPA). , 2010, Cancer genomics & proteomics.

[45]  N. Iizuka,et al.  Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. , 2008, International journal of oncology.

[46]  H. Knull,et al.  Association of glycolytic enzymes with the cytoskeleton. , 1992, Current topics in cellular regulation.